ABU DHABI —The consolidated net profit of the Gulf Pharmaceutical Industries (Julphar) during the first nine months of the current financial year jumped to Dh75.55 million as against Dh45.138 million in the comparable period last year.
The net profit during the third quarter was Dh31.425 million against Dh12.627 million in the same quarter of previous year. The sales revenue rose to Dh394.780 million against Dh331.221 million, during the first three quarters of the previous year. The cost of sales went up to Dh195.347 million during the first nine months of 2005, from its previous level of Dh170.186 million.
The income from investment in shares was seen at Dh13.32 million. The distribution expenses also rose during the period under review to Dh113.202 million from Dh90.560 million.